Stem cell factor affects fate determination of human gonocytes in vitro

Loading....

Loading....

Loading....

Loading....

Loading....

Full text

(1)

REPRODUCTION

RESEARCH

Stem cell factor affects fate determination of human gonocytes

in vitro

Jiongjiong Tu

1,2

, Liqing Fan

1,2

, Ke Tao

2

, Wenbing Zhu

2

, Jianjun Li

3

and Guangxiu Lu

1,2

1National Center of Human Stem Cell Research and Engineering,2Institute of Human Reproduction and Stem Cell

Engineering, Central South University, Changsha, Hunan 410078, China and3Changsha Maternity and Child Health

Hospital, Changsha, Hunan 410007, China

Correspondence should be addressed to G Lu; Email: lugxdirector@yahoo.com.cn

J Tu and L Fan contributed equally to this work Abstract

The stem cell factor (SCF), binding its tyrosine kinase receptor c-Kit, has been shown to play essential roles in the proliferation, differentiation, and survival of germline cells. However, few reports are available about the effect of SCF on the development of human gonocytes within the fetal testis. The objective of this study was to investigate whether SCF affects the biological behaviors of human gonocytes before or after they enter the mitotic arrest stage. Employing an organ culture system, we observed that addition of exogenous SCF could influence the morphology of human gonocytesin vitro. Moreover, SCF was able to trigger the colony formation of round gonocytes, which were characterized positive for alkaline phosphatase activity, Oct-4, SSEA-4, and c-Kit as well. We found that SCF exerted actions in a dose- and age-dependent manner, although the stimulatory effect lasted no more than 14 days. We also showed that SCF played a role in suppressing the apoptosis of human gonocytes. Blocking of SCF signaling with either phosphatidylinositol 3-kinase or mitogen-activated protein kinase inhibitor resulted in similar apoptotic features as well as the SCF-withdrawal cultures. Taken together, we report that SCF acts as a potent regulator in the fate determination of human gonocytes. Our studies should form the basis forin vitro

studies and facilitate investigation of the molecular mechanisms underlying this unique stage. Reproduction(2007)134757–765

Introduction

Male germline development is a highly ordered and complex process. In early gametogenesis, human gonocytes arise when their precursors, primordial germ cells (PGCs), migrate into the embryonic genital ridge and become enclosed in the primitive seminiferous cords by 7 weeks of gestation (Wartenberg 1981). The gonocytes gradually reduce their mitotic cycles and enter the mitotic arrest stage by 16–18 weeks of gestation (Goto et al. 1999). Thereafter, a large number of gonocytes are committed to undergo apoptosis and the survivors differentiate to spermatogonial stem cells, which will initiate the wave of spermatogenesis in puberty (Helal et al. 2002). However, the precise mechanisms underlying these complex events are poorly understood.

In mouse embryos, stem cell factor (SCF) is expressed in somatic tissues in a gradient pattern along the pathway of PGC migration, with the highest levels in the genital ridges (Keshetet al. 1991, Matsuiet al. 1991), whereas c-Kit is expressed on PGCs through their migratory phase and until shortly after they cease proliferation in the embryonic gonads (Manova & Bachvarova 1991).

Preliminary studies have reported that mutation of either SCF (Steellocus) or its receptor c-Kit (Wlocus) results in reduced numbers of PGCs (McCoshen & McCallion 1975, Brannanet al. 1992,Buehret al. 1993), and the interactions of SCF/c-Kit increase the proliferation and suppress apoptosis of PGCs and differentiated sperma-togonia cells as well (Dolci et al. 1991, 2001, Godin

et al. 1991,Pesceet al. 1993,Yanet al. 2000). Further studies have revealed that phosphatidylinositol 3-kinase (PI-3K) and MEK are involved in the intracellular signaling of SCF in male germline development (Dolci

et al. 2001,De Miguelet al. 2002).

In humans, SCF has also been found expressed in the surrounding tissues of PGCs, and c-Kit is confined to PGCs as well (Sandlowet al. 1997, Hoyeret al. 2005). When PGCs migrate into the embryonic gonad and differentiate to gonocytes, the Sertoli cells within the primitive seminiferous cords could compensate for the secretion of SCF as well as the tissues along PGCs migration pathway (Strohmeyer et al. 1995). However, the expression of c-Kit is reduced with the developmental age consistent with the low mitotic activity of human gonocytesin vivo(Gaskellet al. 2004,Paulset al. 2006).

(2)

Based on this evidence, we proposed that SCF signaling might play an undefined role in the development of human gonocytes within the fetal testis.

In the present paper, we developed an organ culture system to study human gonocytes in vitro. We tested different doses of SCF on the morphological change and proliferation activity of human gonocytes derived from 12- to 14-week, 16- to 18-week, and 20- to 22-week fetal testes. The SCF-induced gonocyte colonies were characterized by detection of alkaline phosphatase (AP) activity and pluripotent markers. In addition, PI-3K and MEK inhibitors were used to examine the intracellular signaling of SCF in human gonocytes.

Results

SCF affects the morphology of human gonocytesin vitro

The dissociated seminiferous cords, which were mainly composed of gonocytes and primitive Sertoli cells, were cultured in gelatin-coated four-well tissue culture plates with or without SCF. In this organ culture system, different doses of SCF (10 ng/ml, 100 ng/ml and 500 ng/ml) were tested on human gonocytes derived from 12- to 14-week, 16- to 18-week, and 20- to 22-week fetal testes. After 2 days of culture, fibroblast-like Sertoli cells began to firmly attach to the bottom of the plates, while the gonocytes were exposed and anchored on the somatic monolayer. In the SCF-absent controls, most gonocytes developed cytoplasmic exten-sions and converted to spindly shape (Fig. 1A). In contrast, many gonocytes remained in round shape with the addition of SCF (Fig. 1B). In contrast to somatic cells, both the spindly and round gonocytes were positive for AP activity (Fig. 1C and D), which can be easily scored. The statistical data showed that the index of round gonocytes was significantly higher in the SCF-treated cultures, whereas treatments with 10, 100, and 500 ng/ml SCF resulted in no significant differences. The result also showed a less profound effect of SCF on the late gonocytes than on the early gonocytes (Fig. 1E).

Identification of the gonocyte-derived colonies with the stimulation of SCF

After 3 days of stimulation with SCF, colonies could be induced from round gonocytes, and they displayed a broad size distribution ofO2–4 cells,O4–8 cells,O8–16 cells, andO16 cells by AP staining (Fig. 2). In contrast, most spindly gonocytes remained in single or pair pattern and few colonies were observed, suggesting that the round gonocytes retain stronger clonogenic capacity than the spindly ones. The phenotypic characteristics of these gonocyte-derived colonies were examined by immuno-fluorescence staining. As shown in Fig. 3, the gonocyte colonies were stained positive for Oct-4, SSEA-4, and c-Kit, suggesting that these colonies share similar pluripotent

markers as well as embryonic germ cells (EGCs) that were cultured from PGCs (Shamblott et al. 1998, Turnpenny

et al. 2003,Liuet al. 2004,Parket al. 2004,Panet al. 2005). The result also showed that the cultured gonocyte colonies were only dotted stained with c-Kit, suggesting that the c-Kit might be down-regulated in the present culture system. Nevertheless, the results indicated that these gonocyte colonies have an undifferentiated phenotype.

SCF promotes formation of gonocyte colonies in a dose- and age-dependent manner

To examine the dose effect of SCF on the proliferation activity of human gonocytes, the colony number and size was evaluated at days 7 and 14 in the SCF-treated cultures as well as the controls. As shown inFig. 4, few colonies were observed in the SCF-absent controls. The colony number was increased at 10 ng/ml SCF but mainly peaked atO2–4 cells. In contrast, there was a dramatic increase in the colony number and size at 100 or 500 ng/ml SCF in three tested age groups. The maximum dose of 500 ng/ml resulted in no further enhancement, suggesting that 100 ng/ml may be the saturated dose to enhance the proliferation of gonocytes. The statistical data showed significant differences in response to SCF among 12–14 week, 16–18 week, and 20–22 week cultures. The increased colonies, especially those with O8–16 cells and O16 cells, were obviously confined to the early cultures. In addition, the colonies were significantly reduced after day 14 when compared with those at day 7, suggesting that SCF could not support the consistent growth of gonocytes in the present culture system.

We further determined the proliferation activity of human gonocytes using BrdU incorporation tests and 100 ng/ml SCF was added to stimulate colony formation. Consistent with the colony distribution profile, the proliferation index was significantly higher in the SCF-treated cultures, and the early cultures showed a relatively higher incorporation index as well. In contrast to day 7 cultures, the proliferation index was dramatically reduced at day 14 in three tested age groups, suggesting that the proliferation activity of human gonocytes is impaired during the long-term cultures (Fig. 5).

SCF suppresses apoptosis of human gonocytesin vitro

We next examined the anti-apoptotic effect of SCFin vitro. The gonocyte colonies were induced with the addition of 100 ng/ml. At day 7, SCF was removed and the cells were cultured without SCF for 24 h. As shown inFig. 6A, the colonies began to detach from the somatic monolayer and dissociated into single cells with typical apoptotic features such as shrunken membranes. These dissociated cells were confirmed to be apoptotic by TUNEL staining. In contrast, the gonocyte colonies showed intact and integrated appearances in the SCF-present controls. To block the 758 J Tu, L Fan and others

(3)

effect of SCF, PI-3K inhibitor (LY294002) or MEK inhibitor (U0126) was added with SCF in the culture medium. After 24 h incubation, the gonocyte colonies showed similar apoptotic features as well as the SCF-withdrawal con-ditions (Fig. 6A), suggesting that these two kinases are both involved in downstream SCF signaling in human gono-cytes. The statistical data showed that the apoptotic index was dramatically increased in the SCF-withdrawal and inhibitor-treated cultures in contrast to the SCF-present controls in three tested age groups (Fig. 6B).

Discussion

The study of human gonocytes and their niches is of paramount importance to understand the mechanisms of self-renewal and differentiation of these unique germ stem cells. In the present study, we report that SCF maintained round gonocytes and promoted their colony

formation in a dose- and age-dependent manner. SCF also acted as an anti-apoptotic factor in the cultures. To our knowledge, this is the first report describing the regulatory mechanism underlying the development of human gonocytes.

The relative number of spindly versus round gonocytes is difficult to assessin vivo, butin vitrostudies found that there were two obvious distinct morphological categories with the influence of exogenous SCF. The minimum dose of SCF (10 ng/ml) seems to be sufficient to rescue the round gonocytes, whereas no such effect was observed in the controls, although Sertoli cells produce endogenous SCF in a paracrine manner (Strohmeyer et al. 1995). It is possible that these two subpopulations are analogous to the migrating and degenerating gonocytes similar to previous observations in rodents (Orth & Boehm 1990,Hasthorpeet al. 1999).

Orwiget al. (2002)have reported that it is essential for

Figure 1Morphology of human gonocytes after 2 days of culturein vitro. (A and B) Representation of spindly gonocytes in the absence of SCF (A, arrows) and round gonocytes in the presence of SCF (B, arrowheads). (C and D) Representation of AP activity of spindly gonocytes (C, arrows) and round gonocytes (D, arrowheads). (E) Quantifi-cation of the round gonocytes with untreated controls versus stimulation with 10, 100, and 500 ng/ml SCF from 12–14 week, 16–18 week, and 20–22 week age groups. MeansGS.E.M. for

three independent experiments are shown. Note that there was no significant difference within the treatments of 10, 100, and 500 ng/ml SCF and less profound effect of SCF on late gonocytes. ***P!0.001 when compared with controls. Scale barZ50mm.

(4)

gonocytes to change their appearance to acquire migration ability, whereas the rest would undergo apoptosis. In the present study, addition of exogenous SCF may prevent this transformation and keep gonocytes in a relatively stationary status, and the low expression of endogenous SCF by Sertoli cells may account for their morphological change in vitro. However, the effect of exogenous SCF was less profound on late gonocytes, as we have shown. A possible explanation could be that most late gonocytes have already been committed to migration fate prior to culture, and SCF merely works on the residual round ones.

Interestingly, the rescued round gonocytes, rather than the spindly ones, formed colonies with the stimulation of SCF. We found that these gonocyte-derived colonies

expressed pluripotent markers similar to EGCs, which show a well-known pluripotency for the embryonic body formation and differentiation to other cell lineages ( Turn-pennyet al. 2006). Thus, to some degree, SCF contributes to the maintenance of the pluripotency of human gonocytes rather than triggering differentiation as reported in late spermatogonia cells (Fenget al. 2002), suggesting that SCF plays different roles in specific stages. In addition, there are two potential explanations for the reduced c-Kit on the cultured gonocytes. First, the organ culture system that mimics physiology niches may recapitulate the programmed down-regulation of c-Kit as reportedin vivo

(Gaskellet al. 2004,Paulset al. 2006). Secondly, a negative feedback loop model may account for this in that Cbl proteins, a newly established family as components of the

Figure 2 AP staining of the gonocyte-derived colonies ranged fromO2 to 4 cells (A),O4 to 8 cells (B),O8 to 16 cells (C), andO16 cells (D) after 3 days of stimulation with SCF. Scale barZ20mm.

Figure 3 Phenotype of the gonocyte-derived colonies induced by SCF. Immunofluorescence staining showed that Oct-4 and SSEA-4 were strongly positive whereas c-Kit was dotted stained on the membrane of human gonocytes (arrow-heads). Scale barZ50mm.

(5)

ubiquitin ligation machinery, could induce phosphoryl-ation by SCF and, in turn, lead to the degradphosphoryl-ation of c-Kit receptors (Joazeiroet al. 1999,Zenget al. 2005).

On the other hand, we found that SCF was able to activate the proliferation of the less active or quiescent gonocytes beyond 16–18 week of gestation (Goto et al. 1999), suggesting that SCF is a potent mitogen in mediating the mitotic cycles of human gonocytes. The fact that SCF functions in a dose-dependent manner indicates that the low expression of endogenous SCF in the local niches, as well as the effect on morphological determination of human gonocytes, may also be responsible for the occurrence of mitotic arrest in vivo. According to the immunohistochemistry analysis, the early fetal testis houses more c-Kit-positive gonocytes when compared with the late fetal testis (Gaskellet al. 2004,Paulset al. 2006), which agrees well with their age-dependent growth in response to SCF. Thus, the higher expression of c-Kit

could explain the maximum effect of SCF on the early cultures due to the activation of SCF signaling via SCF/c-Kit complexes. Consistent with this idea, studies in mice have shown that late gonocytes are almost c-Kit negative, which leads to the redundant effect of SCF on their colony formation (Yoshinagaet al. 1991,Vincentet al. 1998,Ohta

et al. 2000, Kanatsu- Shinohara et al. 2003, 2004). Although SCF acts as a potent mitogen in the first few days, the overcrowded Sertoli cells associated with gonocytes may release negative factors and mask the effect of SCF during long-term cultures. It has been reported that Sertoli cells not only favor the survival of gonocytes, but also inhibit their colony formationin vitro(Griswold 1995,

Hasthorpe et al. 1999). The strict control of germ cell numbers in the fetal testis may be a protection mechanism to prevent the formation of seminomas derived from the unlimited duplication of germ stem cells, which could be induced by the c-Kit mutations (Kemmeret al. 2004).

Figure 4Effect of SCF on the formation of gonocyte coloniesin vitro. Quantification of the colonies with untreated controls versus stimulation with 10, 100, and 500 ng/ml SCF from 12–14 week, 16–18 week, and 20–22 week age groups. Cumulative colony numbers were evaluated from 100 randomly selected colonies from at least three independent experiments and scored as four size groups ofO2–4 cells,O4–8 cells,O8–16 cells, andO16 cells. Colonies with 1–2 cells were considered to be quiescent and excluded from the figure. MeansGS.E.M. for three independent

experiments are shown. **P!0.01, ***P!0.001 when compared with controls.###P!0.001 when compared with 10 ng/ml groups. There was no significant difference between 100 and 500 ng/ml groups. Note that the maximal effect of SCF was achieved on early gonocytes, and the colony number was reduced after 14 days of culture

(6)

Our results also showed that SCF acts as a survival factor in the culture of human gonocytes. Instead of undergoing apoptosis, the round gonocytes can survive and proliferate with the addition of SCF, suggesting that SCF may have a role in mediating the programmed death of human gonocytes within the developing testis (Helal

et al. 2002). It has been reported that SCF signaling up-regulates the expression of Bcl-2, a prosurvival protein, thereby preventing apoptosis in a number of cell types (Carson et al. 1994, Jin et al. 1998, Zeuner

et al. 2003,Dhandapaniet al. 2005,Kimuraet al. 2005). In this study, we noted that PI-3 and MEK kinase pathway are also involved in the anti-apoptotic mechanism of SCF signaling, which shares a relatively conserved pathway as well as the previous observations in mouse germline cells (Dolci et al. 1991, 2001, Pesce et al. 1993,Yanet al. 2000).

In conclusion, in this paper, we report that SCF is a potent factor that affects the fate determination of human gonocytes, which provides a new insight into the regulatory mechanism underlying this specific stage.

However, the present culture conditions are not optimal for long-term maintenance, and many improvements need to be addressed. Although we demonstrate here that SCF acts as both mitogen and survival factor for human gonocytes, much remains to be studied on the intrinsic regulation of SCF in the fetal testis, which would favor our further understanding of early gameto-genesis in humans.

Materials and Methods

Testis collection

Human fetal testes were obtained as a result of therapeutic termination of pregnancy using a protocol approved by the ethics committee at Central South University of China, and the patients gave their written informed consent according to the national guidelines (Medical Research Council 2001). The testes were collected from fetuses of 12–14 weeks (nZ9), 16–18 weeks

(nZ7), and 20–22 weeks (nZ7) of gestation. All terminations

were performed in the Gynecology and Obstetric Clinics, Changsha Maternity & Child Health Hospital. The developmental Figure 5Quantification of BrdU-positive gonocytes at 7 and 14 days with the stimulation of 100 ng/ml SCF. MeansGS.E.M. for three independent

experi-ments are shown. In the left panels, ***P!0.001 when compared with controls. In the right panels, no significant differences were observed. Note that the higher incorporation index was confined to early gonocytes and the index of BrdU-positive gonocytes was reduced after 14 days culturein vitro.

(7)

age of the fetuses was determined by the date of the last menstrual bleeding. Weight and length measurements evaluated at the autopsy were used to assure proper gestational development.

Organ culture

The fetal testes were decapsulated under a stereomicroscope in Hank’s balanced salt solution (HBSS, Gibco) and mechanically dissociated with fine scissors. The spliced tissues were exposed to 1 mg/ml collagenase (type IV, Sigma) and 1 mg/ml DNase I (Sigma) at 378C for 20 min, followed by two washes in Dulbecco’s PBS (DPBS, Gibco) at 40gcentrifugation for 5 min to remove redundant interstitial cells. The fragmented semi-niferous cords were collected at 300gcentrifugation for 5 min and resuspended in culture medium. The resulting seminifer-ous cords were aliquoted into four-well tissue culture plates (Nunclon; Nunc, Roskide, Denmark) pre-coated with 0.1% gelatin. The culture medium was changed every other day in all experiments. Basic culture medium used in this study was Dulbecco’s modified Eagle’s medium (D-MEM) supplemented with 10% fetal bovine serum (FBS), 1!non-essential amino acids (NEAA), 50mM 2-mercaptoethanol, 2 mM glutamine, and 1 mM sodium pyruvate (all from Gibco). To investigate the dose effect of SCF, human recombinant stem cell factor (SCF; R & D Systems, Minneapolis, MN, USA) was added at

0–500 ng/ml in the culture medium. For blocking experiments, PI-3K and MEK inhibitors (Cell Signaling Technology, Beverly, MA, USA) were used at conventional concentration of 10mM as reported (Dolciet al. 2001). All cultures were maintained at 378C in a humidified 5% CO2atmosphere.

AP staining and colony counting

To examine endogenous AP activity, cultured cells were fixed with 4% paraformaldehyde and stained with Fast Red Substrate Pack (Zymed) by following the manufacturer’s instructions. According to the AP staining, the gonocyte-derived colonies were counted and grouped asO2–4 cells,O4–8 cells,O8–16 cells, andO16 cells. Single or paired gonocytes were excluded for being considered quiescent.

Immunofluorescence staining

Cultured cells were fixed in 4% paraformaldehyde in PBS at room temperature for 20 min and blocked with PBS containing 0.1% Triton X-100, 4% normal goat serum, and 1% BSA at room temperature for 1 h. The cells were incubated with primary antibodies at 48C overnight. The primary antibodies against human Oct-4 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and SSEA-4 (Chemicon International, Temecula, CA, USA) were Figure 6Effect of SCF on suppressing apoptosis of human gonocytes in vitro. (A) Representation of apoptotic features of gonocytes with the treatments of SCF (100 ng/ml), SCF-withdrawal, SCF plus LY294002, and SCF plus U0126 for 24 h. Note that the single cells dissociated from the colonies were stained with TUNEL-positive signals (arrowheads). (B) Quantification of TUNEL signals showed significant apoptosis in the SCF-withdrawal, SCF plus LY294002, and SCF plus U0126 cultures. MeansGS.E.M. for three independent experiments

are shown. ***P!0.001 when compared with SCF-present controls. Scale barZ50mm.

(8)

diluted at 1:100, and antibody against human c-Kit (DAKO Corporation, Carpinteria, CA, USA) was diluted at 1:300. After washing thrice with PBS, fluorescein isothiocyanate (FITC)- or rhodamine-conjugated secondary antibody (both from Santa Cruz Biotechnology) diluted at 1:100 was added and incubated at 378C for 1 h. Negative controls incubated with PBS instead of primary antibodies revealed no positive staining.

5-Bromodeoxyuridine (BrdU) labeling

To determine cell proliferation, BrdU (Sigma) was added to the culture medium at a final concentration of 10mM. After 24 h incubation, cultured cells were fixed in Bouin’s solution and kept in 70% alcohol. The cells were then denatured with HCl (2 M) for 10 min at room temperature followed by immediate wash with borate buffer (0.1 M) for another 20 min. Unspecific site binding was prevented by blocking with 5% BSA and 1% Triton X-100 in PBS for 1 h. BrdU mouse monoclonal antibody (1:500; Sigma) was used as primary antibody, and anti-mouse FITC (1:100; Santa Cruz Biotechnology) was used as secondary antibody. Nuclear staining was performed by adding 300 nM 4,6-diamidino-2-phenylindole (DAPI; Sigma) for 5 min at room temperature before visualization. The percentage of BrdU/DAPI-labeled nuclei within the colonies was assessed as the proliferation index of gonocytes.

TUNEL assay

TUNEL assay was performed to detect the amount of apoptotic cells within the gonocyte colonies. To induce apoptosis, SCF was removed or co-added with specific kinase inhibitors in the culture medium for 24 h. Cultured cells with different treatments were fixed with 4% paraformaldehyde for 10 min at room temperature and then washed three times in PBS. Staining was performed using a fluorescein-based cell death detection kit (Roche Applied Science) according to the manufacturer’s recommended protocol to quantify apoptotic cells. Counterstaining with DAPI was used to quantitate the total cell numbers of the colonies. The percentage of TUNEL/DAPI-labeled nuclei within the colonies was assessed as the index of apoptosis.

Statistical analysis

All experiments were repeated independently at least thrice in duplicate. The values from all experiments were used for calculation of the means and their respective standard errors of the mean (S.E.M). Statistical tests of one-way ANOVA followed

by the non-parametric test of Kruskal–Wallis were used to determine the significant differences between different experi-mental groups and the controls. The P values !0.05 were considered statistically significant.

Acknowledgements

We thank Profs Guangying Lu and Liansheng Chen for their helpful suggestions. Supported by National Nature Science

Foundation of China (No. 30170480 and No. 30470884). The authors declare that there is no conflict of interest that would prejudice the impartiality of this scientific work.

References

Brannan CI, Bedell MA, Resnick JL, Eppig JJ, Handel MA, Williams DE, Lyman SD, Donovan PJ, Jenkins NA & Copeland NG1992 Develop-mental abnormalities in Steel17Hmice result from a splicing defect in the steel factor cytoplasmic tail.Genes and Development61832–1842. Buehr M, McLaren A, Bartley A & Darling S 1993 Proliferation and

migration of primordial germ cells in We/We mouse embryos.

Developmental Dynamics198182–189.

Carson WE, Haldar S, Baiocchi RA, Croce CM & Caligiuri MA1994 The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2.PNAS917553–7557.

Dhandapani KM, Wade FM, Wakade C, Mahesh VB & Brann DW2005 Neuroprotection by stem cell factor in rat cortical neurons involves AKT and NFkB.Journal of Neurochemistry959–19.

Dolci S, Williams DE, Ernst MK, Resnick JL, Brannan CI, Lock LF, Lyman SD, Boswell HS & Donovan PJ1991 Requirement for mast cell growth factor for primordial germ cell survival in culture.Nature352809–811. Dolci S, Pellegrini M, Di Agostino S, Geremia R & Rossi P2001 Signaling

through extracellular signal-regulated kinase is required for spermato-gonial proliferative response to stem cell factor. Journal of Biological Chemistry27640225–40233.

Feng LX, Chen Y, Dettin L, Pera RA, Herr JC, Goldberg E & Dym M2002 Generation and in vitrodifferentiation of a spermatogonial cell line.

Science297392–395.

Gaskell TL, Esnal A, Robinson LL, Anderson RA & Saunders PT 2004 Immunohistochemical profiling of germ cells within the human fetal testis: identification of three subpopulations.Biology of Reproduction71 2012–2021.

Godin I, Deed R, Cooke J, Zsebo K, Dexter M & Wylie CC1991 Effects of the steel gene product on mouse primordial germ cells in culture.Nature 352807–809.

Goto T, Adjaye J, Rodeck CH & Monk M1999 Identification of genes expressed in human primordial germ cells at the time of entry of the female germline into meiosis. Molecular Human Reproduction 9 851–860.

Griswold MD1995 Interactions between germ cells and Sertoli cells in the testis.Biology of Reproduction52211–216.

Hasthorpe S, Barbic S, Farmer PJ & Hutson JM1999 Neonatal mouse gonocyte proliferation assayed by an in vitro clonogenic method.

Reproduction116335–344.

Helal MA, Mehmet H, Thomas NS, Cox PM, Ralph DJ, Bajoria R & Chatterjee R2002 Ontogeny of human fetal testicular apoptosis during first, second, and third trimesters of pregnancy. Journal of Clinical Endocrinology and Metabolism871189–1193.

Hoyer PE, Byskov AG & Mollgard K2005 Stem cell factor and c-Kit in human primordial germ cells and fetal ovaries.Molecular and Cellular Endocrinology2341–10.

Jin L, Asano H & Blau CA1998 Stimulating cell proliferation through the pharmacologic activation of c-kit.Blood91890–897.

Joazeiro CA, Wing SS, Huang H, Leverson JD, Hunter T & Liu YC1999 The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase.Science286309–312.

Kanatsu-Shinohara M, Ogonuki N, Inoue K, Miki H, Ogura A, Toyokuni S & Shinohara T 2003 Long-term proliferation in culture and germline transmission of mouse male germline stem cells.Biology of Reproduction 69612–616.

Kanatsu-Shinohara M, Inoue K, Lee J, Yoshimoto M, Ogonuki N, Miki H, Baba S, Kato T, Kazuki Y, Toyokuni S, et al. 2004 Generation of pluripotent stem cells from neonatal mouse testis.Cell1191001–1012. Kemmer K, Corless CL, Fletcher JA, McGreevey L, Haley A, Griffith D, Cummings OW, Wait C, Town A & Heinrich MC2004 KIT mutations are common in testicular seminomas. American Journal of Clinical Pathology164305–313.

(9)

Keshet E, Lyman SD, Williams DE, Anderson DM, Jenkins NA, Copeland NG & Parada LF1991 Embryonic RNA expression patterns of the c-kit receptor and its cognate ligand suggest multiple functional roles in mouse development.EMBO Journal102425–2435.

Kimura S, Kawakami T, Kawa Y, Soma Y, Kushimoto T, Nakamura M, Watabe H, Ooka S & Mizoguchi M2005 Bcl-2 reduced and fas activated by the inhibition of stem cell factor/KIT signaling in murine melanocyte precursors.Journal of Investigative Dermatology124229–234. Liu S, Liu H, Pan Y, Tang S, Xiong J, Hui N, Wang S, Qi Z & Li L2004 Human

embryonic germ cells isolation from early stages of post-implantation embryos.Cell and Tissue Research318525–531.

Manova K & Bachvarova RF1991 Expression of c-kit encoded at theW

locus of mice in developing embryonic germ cells and presumptive melanoblasts.Developmental Biology146312–324.

Matsui Y, Toksoz D, Nishikawa S, Nishikawa S, Williams D, Zsebo K & Hogan BL1991 Effect of steel factor and leukaemia inhibitory factor on murine primordial germ cells in culture.Nature353750–752. McCoshen JA & McCallion KJ1975 A study of the primordial germ cells during

their migratory phase in steel mutant mice.Experientia31589–590. Medical Research Council2001Human Tissue and Biological Samples for

Use in Research: Operational and Ethical Guidelines, London: MRC Ethics Series.

De Miguel MP, Cheng L, Holland EC, Federspiel MJ & Donovan PJ2002 Dissection of the c-Kit signaling pathway in mouse primordial germ cells by retroviral-mediated gene transfer.PNAS9910458–10463. Ohta H, Yomogida K, Dohmae K & Nishimune Y2000 Regulation of

proliferation and differentiation in spermatogonial stem cells: the role of c-kit and its ligand SCF.Development1272125–2131.

Orth JM & Boehm R1990 Functional coupling of neonatal rat Sertoli cells and gonocytes in coculture.Endocrinology1272812–2820.

Orwig KE, Ryu BY, Avarbock MR & Brinster RL2002 Male germ-line stem cell potential is predicted by morphology of cells in neonatal rat testes.

PNAS9911706–11711.

Pan Y, Chen X, Wang S, Yang S, Bai X, Chi X, Li K, Liu B & Li L2005In vitro

neuronal differentiation of cultured human embryonic germ cells.

Biochemical and Biophysical Research Communications327548–556. Park JH, Kim SJ, Lee JB, Song JM, Kim CG, Roh S II & Yoon HS2004 Establishment of a human embryonic germ cell line and comparison with mouse and human embryonic stem cells.Molecules and Cells17309–315. Pauls K, Schorle H, Jeske W, Brehm R, Steger K, Wernert N, Buttner R & Zhou H2006 Spatial expression of germ cell markers during maturation of human fetal male gonads: an immunohistochemical study.Human Reproduction21397–404.

Pesce M, Farrace MG, Piacentini M, Dolci S & De Felici M1993 Stem cell factor and leukemia inhibitory factor promote primordial germ cell survival by suppressing programmed cell death (apoptosis).

Development 1181089–1094.

Sandlow JI, Feng HL & Sandra A1997 Localization and expression of the c-kit receptor protein in human and rodent testis and sperm.Urology49 494–500.

Shamblott MJ, Axelman J, Wang S, Bugg EM, Littlefield JW, Donovan PJ, Blumenthal PD, Huggins GR & Gearhart JD 1998 Derivation of pluripotent stem cells from cultured human primordial germ cells.

PNAS9513726–13731.

Strohmeyer T, Reese D, Press M, Ackermann R, Hartmann M & Slamon D 1995 Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue.Journal of Urology153511–515.

Turnpenny L, Brickwood S, Spalluto CM, Piper K, Cameron IT, Wilson DI & Hanley NA 2003 Derivation of human embryonic germ cells: an alternative source of pluripotent stem cells.Stem Cells21598–609. Turnpenny L, Spalluto CM, Perrett RM, O’Shea M, Hanley KP,

Cameron IT, Wilson DI & Hanley NA 2006 Evaluating human embryonic germ cells: concord and conflict as pluripotent stem cells.Stem Cells 24 212–220.

Vincent S, Segretain D, Nishikawa S, Nishikawa SI, Sage J, Cuzin F & Rassoulzadegan M1998 Stage-specific expression of the Kit receptor and its ligand (KL) during male gametogenesis in the mouse: a Kit-KL interaction critical for meiosis.Development1254585–4593. Wartenberg H 1981 Differentiation and development of the testes. In

The Testis, 2 edn, pp 39–81. Eds H Burger & DM de Kretser. New York: Raven Press.

Yan W, Suominen J & Toppari J2000 Stem cell factor protects germ cells from apoptosisin vitro.Journal of Cell Science113161–168. Yoshinaga K, Nishikawa S, Ogawa M, Hayashi S, Kunisada T, Fujimoto T &

Nishikawa S1991 Role of c-kit in mouse spermatogenesis: identification of spermatogonia as a specific site of c-kit expression and function.

Development113689–699.

Zeng S, Xu Z, Lipkowitz S & Longley JB2005 Regulation of stem cell factor receptor signaling by Cbl family proteins (Cbl-b/c-Cbl). Blood 105 226–232.

Zeuner A, Pedini F, Signore M, Testa U, Pelosi E, Peschle C & De Maria R 2003 Stem cell factor protects erythroid precursor cells from chemo-therapeutic agents via up-regulation of BCL-2 family proteins.Blood102 87–93.

Received 8 April 2007 First decision 11 May 2007

Revised manuscript received 11 June 2007 Accepted 29 August 2007

Figure

Updating...

References

Updating...

Related subjects :